Scibetta James S

SEC source: 0001493152-23-039337 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437,244

Underlying: Common Stock · 437,244 shares

Expires 2033-11-01

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0001493152-22-032688 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,657

Underlying: Common Stock · 142,657 shares

Expires 2032-11-14

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0001493152-21-026990 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,882

Underlying: Common Stock · 90,882 shares

Expires 2031-11-01

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-21-000828 · matinasbio_fm4jun192021.xml · derivative · entry 3

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the "Certificate") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date.

F2 · derivative.expiration_date: On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the "Certificate") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date.

SEC source: 0000905718-21-000828 · matinasbio_fm4jun192021.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 649,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the "Certificate") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date.

SEC source: 0000905718-21-000828 · matinasbio_fm4jun192021.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625,958

F1 · kind: Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock.

SEC source: 0001214659-21-006715 · marketforms-53151.xml · derivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001493152-20-020924 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,605

Underlying: Common Stock · 122,605 shares

Expires 2030-11-02

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0001493152-20-011759 · ownership.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 621,158

F1 · kind: Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock.

SEC source: 0001214659-20-005759 · marketforms-49055.xml · derivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 14,000 shares

Expires 2030-06-16

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 16, 2021, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0001493152-20-000126 · ownership.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 617,558

F1 · shares: On December 31, 2019, the Reporting Person was issued 8,260 shares of common stock par value $.0001 per share pursuant to the Issuer's Amended and Restated 2013 Equity Incentive Plan. Such shares vest immediately upon grant.

SEC source: 0001493152-19-016455 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,416

Underlying: Common Stock · 107,416 shares

Expires 2029-11-01

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0001493152-19-014910 · ownership.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606,898

F1 · shares: On September 30, 2019, the Reporting Person was issued 29,739 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0001214659-19-005414 · marketforms-45533.xml · nonDerivative · entry 3

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,635

SEC source: 0001214659-19-005414 · marketforms-45533.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,735

SEC source: 0001214659-19-005414 · marketforms-45533.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,425

SEC source: 0001493152-19-010200 · ownership.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 577,159

F1 · shares: On June 30, 2019, the Reporting Person was issued 21,879 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0001493152-19-014910 · ownership.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,298

F2 · kind: Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock.

SEC source: 0001214659-19-004244 · marketforms-45224.xml · derivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,350

Underlying: Common Stock · 13,350 shares

Expires 2029-06-13

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 13, 2020, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0000905718-19-000325 · matinas_fm4mar312019.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,280

F1 · shares: On March 31, 2019, the Reporting Person was issued 17,202 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-19-000019 · ownership.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,078

F1 · shares: On December 31, 2018, the Reporting Person was issued 31,513 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000910 · ownership.xml · derivative · entry 2

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

SEC source: 0000905718-18-000910 · ownership.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,299

Underlying: Common Stock · 128,299 shares

Expires 2028-10-31

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2018. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.

SEC source: 0000905718-18-000819 · scibetta_form4jun292018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,565

F1 · shares: On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On Octopber 1, 2018, the Reporting Person was granted 20,381 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0001140361-18-033741 · form4.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,700

Underlying: Common Stock · 26,700 shares

Expires 2028-07-24

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date.

SEC source: 0000905718-18-000624 · scibetta_form4jun292018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 486,184

F1 · shares: On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

F1 · price: On June 29, 2018, the Reporting Person was granted 43,203 shares of common stock par value $.0001 per share pursuant to the Company's 2013 Equity Compensation Plan. Such shares vest immediately upon grant.

SEC source: 0000905718-18-000592 · scibetta_form4jun212018.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12

Underlying: Common Stock · 24,000 shares

Expires not disclosed

F1 · derivative.exercise_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

F1 · derivative.expiration_date: On June 21, 2018, the Reporting Person purchased 12 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date.

SEC source: 0000905718-18-000361 · scibetta_form4mar302018.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,981

F1 · shares: On March 30, 2018, the Reporting Person was issued 24,672 shares of common stock par value $.0001 per share which vest immediately upon grant.

SEC source: 0000905718-17-000823 · scibetta_form4sep72017.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 418,309

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.37, inclusive. The reporting person undertakes to provide Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001209191-17-038420 · doc4.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,118

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

SEC source: 0001209191-17-033404 · doc4.xml · derivative · entry 3

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,251

Underlying: Common Stock · 20,000 shares

Expires 2020-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.

SEC source: 0001209191-17-033404 · doc4.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,084

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.60, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-033404 · doc4.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001209191-17-004637 · doc4.xml · derivative · entry 6

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,251

Underlying: Common Stock · 17,627 shares

Expires 2020-12-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests as to 25% of the option shares on December 29, 2011 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. The option shares become exercisable, to the extent vested, from and after the Issuer's initial public offering.

SEC source: 0001209191-17-004637 · doc4.xml · derivative · entry 5

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,373 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering.

SEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 4

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,084

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.05, inclusive.

SEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 3

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,081

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.80 to $38.75, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.

SEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001209191-17-004637 · doc4.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001209191-16-154558 · doc4.xml · derivative · entry 1

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2026-12-07

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

SEC source: 0001209191-16-150960 · doc4.xml · derivative · entry 3

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,373

Underlying: Common Stock · 20,000 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 50% of the options on September 2, 2010 and vests as to the remaining options in successive equal monthly installments for the subsequent 24 months. The options become exercisable, to the extent vested, from and after the issuer's initial public offering.

SEC source: 0001209191-16-150960 · doc4.xml · nonDerivative · entry 2

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,084

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001209191-16-150960 · doc4.xml · nonDerivative · entry 1

Scibetta James S · CIK 0001383242 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,084

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.